Patent: 8,609,142
✉ Email this page to a colleague
Summary for Patent: 8,609,142
| Title: | Drug loaded polymeric nanoparticles and methods of making and using same |
| Abstract: | The present disclosure generally relates to methods of making nanoparticles having about 0.2 to about 35 weight percent of a therapeutic agent; and about 10 to about 99 weight percent of biocompatible polymer such as a diblock poly(lactic) acid-poly(ethylene)glycol. |
| Inventor(s): | Troiano; Greg (Pembroke, MA), Figa; Michael (Allston, MA), Sabnis; Abhimanyu (Arlington, MA) |
| Assignee: | BIND Therapeutics, Inc. (Cambridge, MA) |
| Application Number: | 13/713,553 |
| Patent Claims: | see list of patent claims |
Details for Patent 8,609,142
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Recordati Rare Diseases, Inc. | ELSPAR | asparaginase | For Injection | 101063 | 01/10/1978 | ⤷ Try a Trial | 2028-06-16 |
| Clinigen, Inc. | PROLEUKIN | aldesleukin | For Injection | 103293 | 05/05/1992 | ⤷ Try a Trial | 2028-06-16 |
| Genentech, Inc. | RITUXAN | rituximab | Injection | 103705 | 11/26/1997 | ⤷ Try a Trial | 2028-06-16 |
| Idec Pharmaceuticals Corp. | RITUXAN | rituximab | Injection | 103737 | 02/19/2002 | ⤷ Try a Trial | 2028-06-16 |
| Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 09/25/1998 | ⤷ Try a Trial | 2028-06-16 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
